AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service
Karachi, GlaxoSmithKline Pakistan. NC (GLAXO), a significant entity in the pharmaceutical industry since 1953, maintained consistent market performance in 2023. The company’s stock traded at a high rate of Rs. 83.70 and a low rate of Rs. 84.16. With a paid-up capital of Rs. 3,184.67 million, GlaxoSmithKline Pakistan reported an EPS of Rs. 68 for the year. No distributions were announced for 2022 or 2023.
Check Also
SIFC Playing Key Role in Promoting Industrial Development
Islamabad: Special Investment Facilitation Council (SIFC) is playing a key role in promoting industrial development, investment, and export-oriented sectors in Pakistan. According to Radio Pakistan, the Pakistan-China sports footwear cooperation ag...